2. Lublin FD

Reingold SC

the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 46 : 907-911 View in Article PubMed

Crossref

Google Scholar

3. Marburg O Die sogenannte “akute Multiple Sklerose”. Jahrb Psychiatrie. 27 : 211-312 View in Article Google Scholar

7. Hohlfeld R

Wekerle H Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines. Proc Natl Acad Sci USA. 101 : 14599-14606 View in Article Scopus (171)

PubMed

Crossref

Google Scholar

10. Schuh C

Wimmer I

Hametner S

et al. Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol. 128 : 247-266 View in Article Scopus (2)

PubMed

Crossref

Google Scholar

11. Sawcer S

Hellenthal G

Pirinen M

et al.

the International Multiple Sclerosis Genetics Consortium

the Wellcome Trust Case Control Consortium 2 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 476 : 214-219 View in Article Scopus (620)

PubMed

Crossref

Google Scholar

14. Skulina C

Schmidt S

Dornmair K

et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci USA. 101 : 2428-2433 View in Article Scopus (184)

PubMed

Crossref

Google Scholar

16. Fischer MT

Sharma R

Lim JL

et al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 135 : 886-899 View in Article Scopus (56)

PubMed

Crossref

Google Scholar

21. Brownell B

Hughes JT The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry. 25 : 315-320 View in Article PubMed

Crossref

Google Scholar

22. Holland CM

Charil A

Csapo I

et al. The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis. J Neuroimaging. 22 : 129-136 View in Article Scopus (6)

PubMed

Crossref

Google Scholar

23. Hallgren B

Sourander P The effect of age on the non-haemin iron in the human brain. J Neurochem. 3 : 41-51 View in Article PubMed

Crossref

Google Scholar

24. Hametner S

Wimmer I

Haider L

Pfeifenbring S

Brück W

Lassmann H Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol. 74 : 848-861 View in Article Scopus (19)

PubMed

Crossref

Google Scholar

25. Lansley J

Mataix-Cols D

Grau M

Radua J

Sastre-Garriga J Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability. Neurosci Biobehav Rev. 37 : 819-830 View in Article Scopus (11)

PubMed

Crossref

Google Scholar

26. Mycko MP

Brosnan CF

Raine CS

Fendler W

Selmaj KW Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes. J Neurosci Res. 90 : 1941-1948 View in Article Scopus (4)

PubMed

Crossref

Google Scholar

27. Graumann U

Reynolds R

Steck AJ

Schaeren-Wiemers N Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13 : 554-573 View in Article PubMed

Crossref

Google Scholar

28. Cunnea P

Mháille AN

McQuaid S

Farrell M

McMahon J

FitzGerald U Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis. Mult Scler. 17 : 808-818 View in Article Scopus (12)

PubMed

Crossref

Google Scholar

30. Vergo S

Craner MJ

Etzensperger R

et al. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model. Brain. 134 : 571-584 View in Article Scopus (45)

PubMed

Crossref

Google Scholar

31. di Nuzzo L

Orlando R

Nasca C

Nicoletti F Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. Drug Des Devel Ther. 8 : 555-568 View in Article PubMed

Google Scholar

32. de Vries HE

Witte M

Hondius D

et al. Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?. Free Radic Biol Med. 45 : 1375-1383 View in Article Scopus (119)

PubMed

Crossref

Google Scholar

37. Trapp BD

Peterson J

Ransohoff RM

Rudick R

Mörk S

Bö L Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 338 : 278-285 View in Article Scopus (2492)

PubMed

Crossref

Google Scholar

38. Bjartmar C

Kidd G

Mörk S

Rudick R

Trapp BD Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol. 48 : 893-901 View in Article Scopus (325)

PubMed

Crossref

Google Scholar

41. Wujek JR

Bjartmar C

Richer E

et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol. 61 : 23-32 View in Article PubMed

Crossref

Google Scholar

42. Mews I

Bergmann M

Bunkowski S

Gullotta F

Brück W Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler. 4 : 55-62 View in Article PubMed

Crossref

Google Scholar

43. Peterson JW

Bö L

Mörk S

Chang A

Trapp BD Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 50 : 389-400 View in Article Scopus (719)

PubMed

Crossref

Google Scholar

44. Calabrese M

Agosta F

Rinaldi F

et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol. 66 : 1144-1150 View in Article Scopus (161)

PubMed

Crossref

Google Scholar

45. Nielsen AS

Kinkel RP

Madigan N

Tinelli E

Benner T

Mainero C Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology. 81 : 641-649 View in Article Scopus (9)

PubMed

Crossref

Google Scholar

46. Chang A

Staugaitis SM

Dutta R

et al. Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann Neurol. 72 : 918-926 View in Article Scopus (18)

PubMed

Crossref

Google Scholar

47. Lucchinetti CF

Popescu BF

Bunyan RF

et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med. 365 : 2188-2197 View in Article PubMed

Crossref

Google Scholar

48. Bø L

Vedeler CA

Nyland HI

Trapp BD

Mørk SJ Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 62 : 723-732 View in Article PubMed

Crossref

Google Scholar

50. Choi SR

Howell OW

Carassiti D

et al. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain. 135 : 2925-2937 View in Article Scopus (37)

PubMed

Crossref

Google Scholar

51. Howell OW

Reeves CA

Nicholas R

et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 134 : 2755-2771 View in Article Scopus (88)

PubMed

Crossref

Google Scholar

55. Vercellino M

Masera S

Lorenzatti M

et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol. 68 : 489-502 View in Article Scopus (74)

PubMed

Crossref

Google Scholar

56. Dutta R

Chang A

Doud MK

et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol. 69 : 445-454 View in Article Scopus (39)

PubMed

Crossref

Google Scholar

57. Dutta R

Chomyk AM

Chang A

et al. Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors. Ann Neurol. 73 : 637-645 View in Article Scopus (13)

PubMed

Crossref

Google Scholar

58. Evangelou N

DeLuca GC

Owens T

Esiri MM Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain. 128 : 29-34 View in Article Scopus (63)

PubMed

Crossref

Google Scholar

59. De Stefano N

Matthews PM

Filippi M

et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology. 60 : 1157-1162 View in Article PubMed

Crossref

Google Scholar

60. Androdias G

Reynolds R

Chanal M

Ritleng C

Confavreux C

Nataf S Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann Neurol. 68 : 465-476 View in Article Scopus (25)

PubMed

Crossref

Google Scholar

64. Albert M

Antel J

Brück W

Stadelmann C Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol. 17 : 129-138 View in Article Scopus (90)

PubMed

Crossref

Google Scholar

66. Prineas JW

Barnard RO

Revesz T

Kwon EE

Sharer L

Cho ES Multiple sclerosis. pathology of recurrent lesions. Brain. 116 : 681-693 View in Article PubMed

Crossref

Google Scholar

67. Rodgers JM

Robinson AP

Miller SD Strategies for protecting oligodendrocytes and enhancing remyelination in multiple sclerosis. Discov Med. 16 : 53-63 View in Article PubMed

Google Scholar

68. Storch MK

Stefferl A

Brehm U

et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8 : 681-694 View in Article PubMed

Crossref

Google Scholar

69. Merkler D

Ernsting T

Kerschensteiner M

Bruck W

Stadelmann C A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination. Brain. 129 : 1972-1983 View in Article Scopus (93)

PubMed

Crossref

Google Scholar

70. Pomeroy IM

Matthews PM

Frank JA

Jordan EK

Esiri MM Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain. 128 : 2713-2721 View in Article Scopus (58)

PubMed

Crossref

Google Scholar

71. Beecham AH

Patsopoulos NA

Xifara DK

et al.

the International Multiple Sclerosis Genetics Consortium (IMSGC)

the Wellcome Trust Case Control Consortium 2 (WTCCC2)

the International IBD Genetics Consortium (IIBDGC) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 45 : 1353-1360 View in Article Scopus (78)

PubMed

Crossref

Google Scholar

72. Hochmeister S

Grundtner R

Bauer J

et al. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol. 65 : 855-865 View in Article Scopus (74)

PubMed

Crossref

Google Scholar

73. Serafini B

Rosicarelli B

Magliozzi R

Stigliano E

Aloisi F Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14 : 164-174 View in Article PubMed

Crossref

Google Scholar

74. Magliozzi R

Howell O

Vora A

et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 130 : 1089-1104 View in Article Scopus (322)

PubMed

Crossref

Google Scholar

75. Meinl E

Krumbholz M

Hohlfeld R B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol. 59 : 880-892 View in Article Scopus (154)

PubMed

Crossref

Google Scholar

78. Mycko MP

Papoian R

Boschert U

Raine CS

Selmaj KW cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity. Brain. 126 : 1048-1057 View in Article Scopus (87)

PubMed

Crossref

Google Scholar

79. Na SY

Cao Y

Toben C

et al. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system. Brain. 131 : 2353-2365 View in Article Scopus (39)

PubMed

Crossref

Google Scholar

80. Saxena A

Bauer J

Scheikl T

et al. Cutting edge: Multiple sclerosis-like lesions induced by effector CD8 T cells recognizing a sequestered antigen on oligodendrocytes. J Immunol. 181 : 1617-1621 View in Article PubMed

Crossref

Google Scholar

81. Linington C

Bradl M

Lassmann H

Brunner C

Vass K Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol. 130 : 443-454 View in Article PubMed

Google Scholar

82. Felts PA

Woolston AM

Fernando HB

et al. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain. 128 : 1649-1666 View in Article Scopus (80)

PubMed

Crossref

Google Scholar

83. Lucchinetti C

Brück W

Parisi J

Scheithauer B

Rodriguez M

Lassmann H Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 47 : 707-717 View in Article Scopus (1636)

PubMed

Crossref

Google Scholar

85. Gray E

Thomas TL

Betmouni S

Scolding N

Love S Elevated myeloperoxidase activity in white matter in multiple sclerosis. Neurosci Lett. 444 : 195-198 View in Article Scopus (28)

PubMed

Crossref

Google Scholar

87. Vogel DY

Vereyken EJ

Glim JE

et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J Neuroinflammation. 10 : 35 View in Article Scopus (28)

PubMed

Crossref

Google Scholar

89. Kolasinski J

Stagg CJ

Chance SA

et al. A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology. Brain. 135 : 2938-2951 View in Article Scopus (21)

PubMed

Crossref

Google Scholar

90. Ohno N

Kidd GJ

Mahad D

et al. Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J Neurosci. 31 : 7249-7258 View in Article Scopus (32)

PubMed

Crossref

Google Scholar

92. Ohno N

Chiang H

Mahad DJ

et al. Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons. Proc Natl Acad Sci USA. 111 : 9953-9958 View in Article PubMed

Crossref

Google Scholar

94. Witte ME

Bø L

Rodenburg RJ

et al. Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol. 219 : 193-204 View in Article Scopus (66)

PubMed

Crossref

Google Scholar

95. Kiryu-Seo S

Ohno N

Kidd GJ

Komuro H

Trapp BD Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci. 30 : 6658-6666 View in Article Scopus (31)

PubMed

Crossref

Google Scholar

96. Andrews H

White K

Thomson C

et al. Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. J Neurosci Res. 83 : 1533-1539 View in Article Scopus (37)

PubMed

Crossref

Google Scholar

99. Dutta R

McDonough J

Yin X

et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol. 59 : 478-489 View in Article Scopus (329)

PubMed

Crossref

Google Scholar

100. Witte ME

Nijland PG

Drexhage JA

et al. Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex. Acta Neuropathol. 125 : 231-243 View in Article Scopus (14)

PubMed

Crossref

Google Scholar

101. Hares K

Kemp K

Rice C

Gray E

Scolding N

Wilkins A Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis. Mult Scler. ( ) http://dx.doi.org/10.1177/1352458513508836 View in Article Google Scholar

102. Harris H

Rubinsztein DC Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol. 8 : 108-117 View in Article Scopus (113)

Crossref

Google Scholar

103. Stromillo ML

Giorgio A

Rossi F

et al. Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. Neurology. 80 : 2090-2094 View in Article Scopus (10)

PubMed

Crossref

Google Scholar

104. Narayanan S

De Stefano N

Francis GS

et al.

the Arnason BGW Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol. 248 : 979-986 View in Article Scopus (117)

PubMed

Crossref

Google Scholar

107. Connor J Iron and glia. in: Kettenmann H Ransom B Neuroglia. Oxford Oxford University Press , : 586-602 View in Article Google Scholar

108. Bagnato F

Hametner S

Yao B

et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain. 134 : 3602-3615 View in Article Scopus (49)

PubMed

Crossref

Google Scholar

109. Mehta V

Pei W

Yang G

et al. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One. 8 : e57573 View in Article Scopus (17)

PubMed

Crossref

Google Scholar

110. Pitt D

Boster A

Pei W

et al. Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol. 67 : 812-818 View in Article Scopus (45)

PubMed

Crossref

Google Scholar

111. Stahnke T

Stadelmann C

Netzler A

Brück W

Richter-Landsberg C Differential upregulation of heme oxygenase-1 (HSP32) in glial cells after oxidative stress and in demyelinating disorders. J Mol Neurosci. 32 : 25-37 View in Article Scopus (44)

PubMed

Crossref

Google Scholar

112. van Horssen J

Schreibelt G

Bö L

et al. NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. Free Radic Biol Med. 41 : 311-317 View in Article Scopus (38)

PubMed

Crossref

Google Scholar

113. van Horssen J

Schreibelt G

Drexhage J

et al. Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression. Free Radic Biol Med. 45 : 1729-1737 View in Article Scopus (88)

PubMed

Crossref

Google Scholar

114. McMahon JM

McQuaid S

Reynolds R

FitzGerald UF Increased expression of ER stress- and hypoxia-associated molecules in grey matter lesions in multiple sclerosis. Mult Scler. 18 : 1437-1447 View in Article Scopus (6)

PubMed

Crossref

Google Scholar

116. Kornek B

Storch MK

Bauer J

et al. Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain. 124 : 1114-1124 View in Article PubMed

Crossref

Google Scholar